Parkinson Disease
📧 Sign up to get email alerts when something new happens for Parkinson Disease.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2014-11-04FDA Approved: CARBIDOPA AND LEVODOPA — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for Teva Pharmaceuticals USA, Inc. for Carbidopa and Levodopa (generic) products.
-
CLINICAL_TRIALS trial_result · 2014-11-03Clinical Trial Update: Development of an Instrumented System to Measure Mobility in Parkinson's Disease
The clinical trial evaluating an instrumented system designed to measure mobility in Parkinson's disease has completed. The sponsor is Orego…
-
CLINICAL_TRIALS trial_result · 2014-11-03Clinical Trial Update: The Effects of Treadmill Versus Agility Training in Parkinson's Disease [NA]
A completed clinical trial evaluated the effects of treadmill training versus agility training in Parkinson's disease.
-
CLINICAL_TRIALS trial_result · 2014-10-31Clinical Trial Update: Efficacy of Orally Disintegrating Selegiline in Parkinson's Patients Experiencing Adverse Effects With Dopamine Agonists [Phase 4]
Phase 4 study evaluating the efficacy of orally disintegrating selegiline in Parkinson's disease patients experiencing adverse effects with …
-
CLINICAL_TRIALS research · 2014-10-27Clinical Trial Update: Pharmacologically Active Constituents of Chocolate and Their Symptomatic Effects in Patients With Idiopathic Parkinson's Disease [NA]
A clinical trial update describing a study of pharmacologically active constituents from chocolate and their potential symptomatic effects i…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2014-10-24Clinical Trial Update: Dietary Modifications Effect on Continuous LCIG Infusion Outcomes in Patients With Advanced Parkinson&Apos;s Disease [NA]
A clinical trial update exploring how dietary modifications affect outcomes of continuous LCIG infusion in advanced Parkinson's disease.
-
CLINICAL_TRIALS trial_result · 2014-10-24Clinical Trial Update: Cognitive Behavioral Therapy for Depression in Parkinson's Disease [NA]
A study evaluating cognitive behavioral therapy for depression in Parkinson's disease was terminated.
-
CLINICAL_TRIALS trial_result · 2014-10-21Clinical Trial Update: Exercise Interventions in Parkinson's Disease [Phase 2]
A Phase 2 clinical trial evaluating exercise interventions for Parkinson's disease has completed.
-
CLINICAL_TRIALS trial_result · 2014-10-20Clinical Trial Update: A Multicenter, Open-label Trial to Assess Subject Preference of PARCOPA, Carbidopa/Levodopa Orally Disintegrating Tablets, Compared to Conventional Carbidopa/Levodopa Tablets in Subjects With Stable Parkinson's Disease [Phase 3]
A Phase 3 open-label trial comparing PARCOPA (carbidopa/levodopa orally disintegrating tablets) with conventional carbidopa/levodopa tablets…
-
CLINICAL_TRIALS research · 2014-10-20Clinical Trial Update: Named Patient Program With Rotigotine Transdermal System
This document reports an update on the named patient program for the rotigotine transdermal system, noting that the program has completed.
-
CLINICAL_TRIALS trial_result · 2014-10-15Clinical Trial Update: Rasagiline as Add on to Dopamine Agonists in the Treatment of Parkinson's Disease [Phase 4]
Phase 4 trial results posted for rasagiline as an add-on therapy to dopamine agonists in Parkinson's disease.
-
CLINICAL_TRIALS trial_result · 2014-10-09Clinical Trial Update: A Follow-up Study on Safety and Tolerability of Intracerebroventricular Administration of sNN0031 to Patients With Parkinson's Disease
This update reports on a completed follow-up study evaluating the safety and tolerability of intracerebroventricularly administered sNN0031 …
-
CLINICAL_TRIALS trial_result · 2014-10-09Clinical Trial Update: Magnetic Resonance (MR) Guided Functional Ultrasound-Neurosurgery for Movement Disorders [Phase 1]
Phase 1 clinical trial update on MR-guided functional ultrasound neurosurgery for movement disorders, including Essential Tremor, Dystonia, …
-
CLINICAL_TRIALS trial_result · 2014-10-03Clinical Trial Update: Anticholinergic Therapy for Overactive Bladder in Parkinson's Disease [NA]
A clinical trial investigating anticholinergic therapy for overactive bladder in Parkinson's disease has completed.
-
FDA approval · 2014-09-30FDA Approved: TASMAR — Supplemental Application (Bausch Health US LLC)
FDA approves a supplemental application for TASMAR (tolcapone) filed by Bausch Health US LLC.
-
CLINICAL_TRIALS trial_result · 2014-09-29Clinical Trial Update: Molecular Epidemiology of Parkinson's Disease
A completed clinical trial sponsored by the National Institute of Environmental Health Sciences investigating the molecular epidemiology of …
-
CLINICAL_TRIALS research · 2014-09-29Clinical Trial Update: Farming and Movement Evaluation Study (FAME)
The Farming and Movement Evaluation Study (FAME) sponsored by NIEHS has completed, examining associations between farming exposures and move…
-
CLINICAL_TRIALS trial_result · 2014-09-26Clinical Trial Update: Neuromodulation on Motor Function in Parkinson's Disease [NA]
A clinical trial update notes a neuromodulation study related to motor function in idiopathic Parkinson's disease, with the current status n…
-
CLINICAL_TRIALS research · 2014-09-26Clinical Trial Update: Development of a Monitoring Set-up and Algorithm Using Functional MRI (fMRI) and EEG for Prediction of Response to Repetitive Deep Transcranial Magnetic Stimulation (rDTMS) for Patients With Parkinson's Disease [NA]
Clinical trial update describing development of a monitoring setup and algorithm using fMRI and EEG to predict response to repetitive deep T…
-
CLINICAL_TRIALS trial_result · 2014-09-25Clinical Trial Update: A Trial to Compare the Efficacy of Rotigotine Transdermal Patch to That of Ropinirole on Early Morning Motor Impairment and Sleep Disorders in Subjects With Early-Stage, Idiopathic Parkinson's Disease [Phase 3]
A Phase 3 randomized trial comparing the rotigotine transdermal patch to ropinirole for early morning motor impairment and sleep disorders i…
-
CLINICAL_TRIALS safety_alert · 2014-09-25Clinical Trial Update: Post Marketing Surveillance And Special Surveillance for Mirapex® Tablet in Patients With Idiopathic Parkinson's Disease
Post-marketing surveillance study for Mirapex (pramipexole) tablets in patients with Parkinson's disease has been completed, focusing on saf…
-
CLINICAL_TRIALS trial_result · 2014-09-25Clinical Trial Update: Efficacy and Tolerability of Sifrol® (Pramipexole) in Patients With Advanced Idiopathic Parkinson's Disease
The report summarizes the completed trial evaluating the efficacy and tolerability of Sifrol (pramipexole) in patients with advanced idiopat…
-
CLINICAL_TRIALS trial_result · 2014-09-25Clinical Trial Update: Tolerability of Sifrol® in Ambulatory Patients Suffering From Parkinson's Disease
A completed trial assessing the tolerability of Sifrol (pramipexole) in ambulatory patients with Parkinson disease.
-
CLINICAL_TRIALS trial_result · 2014-09-25Clinical Trial Update: A Trial to Evaluate the Effects of Rotigotine Transdermal Patch on Early Morning Motor Impairment and Sleep Disorders Idiopathic Parkinson's Disease [Phase 3]
A Phase 3 clinical trial evaluating rotigotine transdermal patch for early morning motor impairment and sleep disorders in Parkinson's disea…
-
CLINICAL_TRIALS trial_result · 2014-09-25Clinical Trial Update: Post Marketing Surveillance Study of Sifrol® in Patients With Idiopathic Parkinson's Disease
A completed post-marketing surveillance study to monitor safety in real-world use of Sifrol (pramipexole) in patients with Parkinson's disea…